Retinal pigment epithelium and age‐related macular degeneration: A review of major disease mechanisms. (17th August 2020)

• Record Type: Journal Article
• Authors: Somasundaran, Shreya; Constable, Ian J.; Mellough, Carla B.; Carvalho, Livia S.
• Is Part Of: Clinical & experimental ophthalmology. Volume 48:Number 8(2020)
• Page Start: 1043
• Page End: 1056
• Publication Date: 2020-08-17
• Subjects: age‐related macular degeneration -- apoptosis -- eye -- necrosis -- retinal pigment epithelium; Ophthalmology -- Periodicals; 617.7
• DOI: 10.1111/ceo.13834
• Languages: English
• ISSNs: 1442-6404

Abstract

Abstract: Age‐related macular degeneration (AMD) is a progressive degenerative disease that is the leading cause of vision loss in the elderly population. Degeneration/dysregulation of the retinal pigment epithelium (RPE), a supportive monolayer of cells underlying the photoreceptors, is commonly seen in patients with AMD. While treatment exists for the neovascular/wet form of AMD, there is currently no cure for the non‐exudative/dry form of AMD, making it imperative to understand the pathogenesis of this disease. Although our understanding of the aetiology of AMD has increased over the years, the underlying disease mechanism has not yet been identified, mainly due to the multifactorial nature of this disease. Herein, we review some of the commonly proposed degeneration pathways of RPE cells and their role in the pathogenesis of AMD; including activation of the complement cascade, oxidative stress‐induced cell death mechanisms, dysfunctional mitochondria and the role of crystallins in AMD disease progression.